Zomedica Corp. (ZOMDF) Return on equity 2020–2025
Zomedica Corp. (ZOMDF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-70.9%FY2025 · since FY2020: -33.1% → -70.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -70.9% | -46.9 pp |
| FY2024 | -24.0% | -9.6 pp |
| FY2023 | -14.4% | -8.0 pp |
| FY2022 | -6.4% | +0.4 pp |
| FY2021 | -6.8% | +26.3 pp |
| FY2020 | -33.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice